rekrunner wrote:
I would say, we can't tell because of steroids. This isn't that hard. Zaripova would be a great example of a slightly different discussion about doping effectiveness, rather than EPO effectiveness.
And in Zaripova's case you have the proof of the confirmed positive for turinabol which would merit the discussion of which PED was more effective from an endurance perspective. However, you're obfuscating on the confirmed cases of O2-vector doping with high achieving female runners with no proof of androgen usage. There are many good examples with top females and these are just a few:
1) Ceplak - 18th fastest all-time 800/EPO positive (no proof of androgens).
2) Stephanie Graf - 157th fastest all-time 800 & silver x2 (Olympics/WC), implicated in an organized blood doping operation (no proof of androgens):
https://en.m.wikipedia.org/wiki/Stephanie_Graf3) Shobukhova - held 2nd fastest marathon all-time behind Radcliff/sanctioned for hematological anomalies (no proof of androgens).
In fact, Shobukhova's case was so egregious that one expert considered her Hgb to be so high it constituted a "medical emergency" ("likely doping?" ?).
"The ABP expert panel concluded that the athlete’s abnormal profile was likely the result
of the use of a prohibited substance or method, specifically blood manipulation with
“massive use of erythropoietin” associated with an autologous blood transfusion
strategy. One expert considered that two of the athlete’s hemoglobin values obtained in
October 2009 and October 2011, in strict correlation with the Chicago Marathon, which
Ms. Shobukhova won both years on 11 October 2009 and 09 October 2011, respectively,
were so high that they should be considered a medical emergency."
https://www.wada-ama.org/sites/default/files/resources/files/wada_independent_commission_report_1_en.pdf